Thorsten Steiner

Thorsten Steiner is an Affiliate Professor in the Department of Clinical Medicine at University of Copenhagen, specializing in Neurology. His research focuses on acute stroke management, particularly intracerebral hemorrhage and related complications. He maintains a dual institutional affiliation, with email contact through Heidelberg University in Germany.

Dr. Steiner's research interests span multiple critical areas in stroke medicine including cerebral edema management, anticoagulant-related hemorrhagic complications, and hematoma expansion prevention. His work combines clinical trial design with epidemiological analysis to address urgent challenges in neurocritical care. He has made significant contributions to understanding sex differences in stroke outcomes and optimizing treatment protocols for hemorrhagic stroke.

His publication record demonstrates a consistent focus on high-impact clinical questions in stroke medicine, with several publications in top-tier journals including The Lancet Neurology and Stroke. His 2016 INCH trial comparing blood products for anticoagulant-related intracranial hemorrhage has been particularly influential with over 300 citations and multiple guideline references. More recently, he has contributed to the CHARM trial investigating glibenclamide for cerebral edema after large hemispheric stroke.

Dr. Steiner's research has received substantial attention in both academic and clinical spheres, with multiple publications picked up by news outlets and referenced in clinical guidelines. His work on the spot sign in intracerebral hemorrhage has generated particular interest in the neurology community.

He actively collaborates with an international network of stroke researchers across Europe and North America, participating in large multi-center clinical trials that have shaped contemporary stroke management protocols. His research bridges basic science with immediate clinical applications, focusing on interventions that can be rapidly implemented in emergency settings.